MIRA INFORM REPORT

 

 

 

Report Date :

21.04.2008

 

IDENTIFICATION DETAILS

 

Name :

AQUATIC REMEDIES PRIVATE LIMITED

 

 

Registered Office :

218/219, Kailash Plaza, Vallabh Baug Lane, Ghatkopar (East), Mumbai – 400075, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

04.03.1996

 

 

Com. Reg. No.:

097828

 

 

CIN No.:

[Company Identification No.]

U24230MH1996PTC097828

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMA11886A

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Importers, Exporter, Manufacturer and Merchant Trading House of Pharmaceutical Raw Materials and Bulk Active Ingredients.

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 287236

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Mr. Santosh Shirsagar, Chief Accountant parted some more details for the report. Mr. Bharat Mehta, Managing Director is out of city.

 

Subject is a well established company having satisfactory track. Trade relations are fair. Financial position is satisfactory.

The company is doing well.

 

It can be considered good for normal business dealings at usual trade terms and conditions.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Santosh Shirsagar

Designation :

Chief Accountant

Date :

17.04.2008

 

 

LOCATIONS

 

Registered Office/ Factory :

218/219, Kailash Plaza, Vallabh Baug Lane, Ghatkopar (East), Mumbai – 400075, Maharashtra, India

Tel. No.:

91-22-67255555/ 55958111

Fax No.:

91-22-67991766

E-Mail :

forum_1979@rediffmail.com

afil@vsnl.net

Website :

http://www.aquaticremedies.net

 

 

DIRECTORS

 

Name :

Mr. Bharat Nyalchand Mehta

Designation :

Chairman cum Managing Director

Address :

255/11 Prity, Ram Narayan Narkar Road, Ghatkopar (East), Mumbai – 400077, Maharashtra, India

Date of Birth/Age :

24.10.1960

Date of Appointment :

04.03.1996

 

 

Name :

Mr. Hitendra Nyalchand Mehta

Designation :

Director

Date of Birth/Age :

09.09.1969

Date of Appointment :

04.03.1996

 

 

Name :

Mrs. Kirti Bhogilal Mehta

Designation :

Director

Date of Birth/Age :

31.12.1970

Date of Appointment :

04.03.1996

 

 

Name :

Mr. Darshan Bhogilal Mehta

Designation :

Director

Date of Birth/Age :

07.07.1977

Date of Appointment :

04.03.1996

 

 

Name :

Mr. Sudhir Kumar Kejriwal

Designation :

Director

Date of Birth/Age :

07.07.1962

Date of Appointment :

01.04.2005

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(As on 30.09.2005)

Names of Shareholders

 

No. of Shares

 

 

 

Mr. Bharat Nyalchand Mehta

 

109700

Mr. Hitendra Nyalchand Mehta

 

40100

Mrs. Kirti Bhogilal Mehta

 

22600

Mr. Darshan Bhogilal Mehta

 

39100

Mrs.Daksha B. Mehta

 

39100

Mrs. Rajeshree M. Mehta

 

30500

Mrs. Bijal K. Mehta

 

2000

Mr. Bharat Nyalchand Mehta (HUF)

 

13000

Mrs. Kirti Bhogilal Mehta (HUF)

 

26500

Mr. Mitesh A. Mehta

 

12500

Mst. Vaibhav Mehta

 

2000

Ms. Mausami B. Mehta

 

50000

Ms. Kajal Mehta

 

2000

Ms. Komal Mehta

 

2000

Ms. Harsh Mehta

 

2000

Mst. Jay M. Mehta

 

2000

Mr. Nyalchand Mehta

 

37000

Mr. Bhogilal Mehta

 

26000

Mr. Nyalchand Mehta (HUF)

 

37000

Mrs. Jayshree M. Mehta

 

17500

Mr. Bhogilal Mehta (HUF)

 

37500

Mrs. Chandrika Mehta

 

28000

Mr. Bharat Nyalchand Mehta (HUF)

 

29500

Mr. Hitendra Nyalchand Mehta (HUF)

 

7500

Mrs. Kirti Bhogilal Mehta (HUF)

 

37000

Mr. Hemant Mehta

 

80000

Mr. Mitesh Mehta

 

26000

Mr. Kamlesh  Jain

 

15000

Mr. Rasiklal Sheth

 

15005

Mr. Nalinkant Shah

 

4900

Mrs. Namita Jain

 

7000

Mr. K P Kucheria

 

5

Mrs. Sheetal Kucheria

 

5

Mr. Yogendra Fattehpuria

 

5

Mr. K P Kucheria

 

5

Mrs. Usha Fattehpuria

 

5

Mrs. Tara Ramniklal Sheth

 

5

Mr. Jas Textiles

 

5

Pet Plastic Limited

 

199960

 

 

 

Total

 

1000000

 

 

(As on 31.03.2007)

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Importers, Exporter, Manufacturer and Merchant Trading House of Pharmaceutical Raw Materials and Bulk Active Ingredients.

 

 

Products :

·       Ethambutol

·       Pyrazinamide

·       Macrolides

·       Steroids

·       Paracetamol

·       Salbutamol Sulphate

·       C.P.Maleate

·       Dex-CPM

·       Azithromycine

·       Dexamethasone Sodium

·       Prednisolone  Acetate

·       Ketaconazole

·       Chloramphenicol Palmitate

·       Sildenafil Citrate

·       Amlodipine Besylate

·       Chloramphenicol Palmitate

·       Ketaconazole

·       Enalapril Maleate

·       Erythromycins

·       Roxythromycin

·       Imipramine

·       Clomipramine

·       Promethazine

·       Cyproheptadine

·       Domperidon

·       Omeprazole

·       Lansoprazole

·       Ornidazole

·       Tinidazole

·       Mebendazole

·       Albendazole

·       Albendazole

·       Frusemide

·       Miconazole Nitrate

·       Ampicillin Sodium Sterile

·       Amoxycillin Sod.  Sterile Cifexime

·       Roxythromycin

 

 

GENERAL INFORMATION

 

No. of Employees :

30

 

 

Bankers :

·       Bank of Maharashtra

Ghatkopar Branch, R B Mehta Marg, Ghatkopar (East), Mumbai – 400077, Maharashtra, India

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

C P Bhatia

Chartered Accountant

Address :

707 B, Arihant, Sudha Park, Shanti Path, Ghatkopar (East), Mumbai – 400077, Maharashtra, India

 

 

Associates/Subsidiaries :

Oceanic Techno Chem Private Limited

255/3, Prity, R.N.N. Road, Ghatkopar (East), Mumbai - 400077, Maharashtra, India

Phone : 91-22-67030777 (3 LINES)

Fax : 91-22-2509 4350

Email :kamlesh563@yahoo.co.in

           hemant0579@yahoo.co.in

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6000000

Equity Shares

Rs.10/- each

Rs.60.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5790000

Equity Shares

Rs.10/- each

Rs.57.900 Millions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2007

31.03.2006

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

57.900

37.900

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

13.909

8.514

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

71.809

46.414

LOAN FUNDS

 

 

 

1] Secured Loans

 

52.474

66.741

2] Unsecured Loans

 

2.965

1.425

TOTAL BORROWING

 

55.439

68.166

DEFERRED TAX LIABILITIES

 

0.000

0.030

 

 

 

 

TOTAL

 

127.248

114.610

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

2.665

2.967

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

22.198

1.124

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
64.272

17.471

 

Sundry Debtors

 
236.064

172.335

 

Cash & Bank Balances

 
2.623

2.409

 

Other Current Assets

 
0.000

0.000

 

Loans & Advances

 
8.047

11.409

Total Current Assets

 
311.006

203.624

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 
208.621

93.105

 

Provisions

 
0.000

0.000

Total Current Liabilities

 
208.621

93.105

Net Current Assets

 
102.385

110.519

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

127.248

114.610

 

 

 

 

 

 

 

 

 

 

 

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2008

31.03.2007

31.03.2006

Sales Turnover

1000.000

(Estimated)

828.206

709.887

Other Income

 

0.000

0.000

Total Income

 

828.206

709.887

 

 

 

 

Profit/(Loss) Before Tax

 

9.684

7.087

Provision for Taxation

 

0.000

0.000

Profit/(Loss) After Tax

 

9.684

7.087

 

 

 

 

Expenditures :

 

 

 

 

Depreciation

 

0.566

0.732

 

Other Expenditure

 

817.956

702.068

Total Expenditure

 

818.522

702.800

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2007

31.03.2006

PAT / Total Income

(%)

 

1.17

0.99

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

1.17

0.99

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

3.09

3.43

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

0.13

0.15

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

 

3.68

3.47

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.49

2.19

 

 

 

 

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Form 8:

 

Name of the company

AQUATIC REMEDIES PRIVATE LIMITED

Presented By

Mr. Bharat N. Mehta

1) Date and description of instrument creating the change

Deed of Hypothecation of Stock and Book Debts date 12.07.1997

2) Amount secured by the charge/amount owing on the securities of charge

Rs.0.950 Million

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

All Debtors of the company for the goods supplied and stock in trade.

 

·       Hypothecation of Stock and Book Debts

·       Hypothecation of Fixed Assets and Office Equipments.

4) Gist of the terms and conditions and extent and operation of the charge.

Interests 6.75 % p.a. OBR 17.75% p.a.

Repayable On Demand

Margin 50% on Book Debts and 25% on Stock

5) Name and Address and description of the person entitled to the charge.

Bank of Maharashtra

Neelkanth Krupa, R B Mehta Marg, Ghatkopar (East), Mumbai – 400077, Maharashtra, India

6) Date  and brief description of instrument modifying the charge

Composite deed of hypothecation for all facilities dated 06.11.1999

 

Cash Credit Rs.7.500 Millions

Inland Letter of Credit Rs.0.026 Million

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Original Charge Dated 12.07.1997 for Rs.0.950 Million 1st modification dated 28.09.1998 Limit increase from Rs.0.950 Million to Rs.3.100 Millions this modifications.

 

All debtors of the company for the goods supplied and stock in trade.

·       Hypothecation of Stock and Book Debts

·       Hypothecation of Fixed Assets and Office Equipments.

 

Interests @17.85% p.a. Quarterly

Repayable On Demand

Repayment – D.A./D. P.

Margin: 25% in Banks Favour.

 

Cash Credit Rs.7.500 Millions

Inland Letter of Credit Rs.0.026 Million

 

Corporate identity number (CIN) Foreign company registration number

U24230MH1996PTC097828

Name of the Company

AQUATIC REMEDIES PRIVATE LIMITED

Address

218/219, Kailash Plaza, Vallabh Baug Lane, Ghatkopar (East), Mumbai – 400075, Maharashtra, India

This form is for

Creations of Charge

Type of Charge

Immovable Property

Particulars of the charge holder 

Bank of Maharashtra

Ghatkopar Branch, R B Mehta Marg, Ghatkopar (East), Mumbai – 400077, Maharashtra, India

bom228@amhabank.co.in

Nature or description of the instrument(s) creating or modifying the charge

Memorandum of Record of Equitable Mortgage

Date of the instrument creating or modifying the charge

30.03.2007

Amount secured by the charge

Rs.60.000 Millions

Brief particulars of the principal terms and conditions and extent and operation of the charge

Rate of Interests:

BPLR @ 11.25% p.a. with monthly rests as per sanction letter dated 10.03.2006. Commission on L/C as per Company Guidelines

 

Terms of Repayment:

Both facilities to be reviewed within in a year and DA bills under L/C not to exceed 90 days tenor

 

Margin:

25% in case of cash credit and 20% in Term Deposit in case of inland letter of credit

 

Extent and operation of the chare:

Charge of hypothecation to cover principal amount of Rs.60.000 Millions ( Cash Credit Rs.30.000 Millions + Rs.30.000 Millions by way of letter of credit ( Import/ inland) plus interests, costs, charges, expenses etc.

Short particulars of the property charged (including location of the property)

Office premises bearing no.218/219 along with all fixture and fittings in building known as kailas plaza admeasuring 632 sq. ft. situated at vallabh baug lane Ghatkopar (east), Mumbai -77, in the revenue village of Ghatkopar, Taluka Kurla Mumbai Situated on Plot of Land bearing No.355, CTS No.5286 B in the Registration District and sub District of Mumbai City and Mumbai Suburb and bounded by various boundaries as per IInd Schedule (B)

Particular of the present modification 

NA

 

 

As per Website

 

Profile:

 

Almost two decades of experience since its inception in 1985, have taken subject from strength to strength in the health care business. A small company started by Mr. Bharat Mehta has grown into a large and dynamic business house which currently occupies a leading position in the fields of Bulk Drugs Pharmaceutical Formulations in the Domestic as well as Export Market. Their Management Team.

 

The company strides to achieve global standards in the field of Pharmaceuticals and bulk drugs. Subject initially started with domestic trading in bulk drugs and gradually ventured into the areas of export, imports, and indenting. Constant diversification and expansion has resulted in creation of large clientele in domestic and international markets and is a contributing factor for the high turnover rate which rose by 400% in the last decade.

 

 

Trade Reference:

 

·       Medchl Limited, Hyderabad

·       Anuh Pharma Limited

·       Vamsi Labs Limited Solapur

·       Supriya Chemicals Solapur

·       Envee Drugs Private Limited

·       Sharon Bio Medicines Limited

·       Harika Drugs Limited

·       Vasudha Pharmachem Private Limited

·       Ultratech Speciality Chemicals Limited

·       Rakshit Drugs Limited

·       Zen Biotech Limited

·       Unidrug Innovatives Limited

·       K.A.Malle Drugs Limited

·       Transchem Limited

·       Sun Shine Chemicals Limited 

·       Concept Pharma Limited 

·       Wang Pharma Limited 

·       Citochem Limited 

·       Tasc Pharmaceuticals Limited  

·       Suchem Lab Limited 

·       Alexo Pharmaceuticals Limited  

·       DSM Limited  

·       Vital Healthcare

·       Quinine Sulphate, Quinine Di HCL

·       Hetero Drugs Limited 

·       Harind Pharmaceuticals Limited 

·       Meditech

·       Lupin Labs

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.39.96

UK Pound

1

Rs.78.66

Euro

1

Rs.63.31

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions